ResMed | RMD - Trade Creditors


ResMed reported $250.41M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Ansell USD 250.9M 25.4M Jun/2025
Artivion USD 16.5M 2.93M Sep/2025
AtriCure USD 78.4M 3.56M Dec/2025
Baxter International USD 999M 46M Dec/2025
Cochlear AUD 298.4M 12.9M Jun/2025
Cooper Companies USD 300.4M 44.5M Sep/2025
CSL USD 3.46B 484M Jun/2025
Dexcom USD 1.83B 1.38B Dec/2025
Edwards Lifesciences USD 165M 94.2M Sep/2025
Fisher Paykel Healthcare NZD 267.8M 4M Dec/2025
Globus Medical USD 98.85M 11.62M Dec/2025
Haemonetics USD 48.69M 13M Dec/2025
Hologic USD 201.1M 573.5M Dec/2025
Idexx Laboratories USD 110.41M 11.86M Dec/2025
Inogen USD 21.22M 684K Sep/2025
Insulet USD 75M 26.8M Dec/2025
Integra LifeSciences USD 92.3M 530K Sep/2025
Intuitive Surgical USD 1.92B 179.7M Dec/2025
Masimo USD 117.9M 17.8M Sep/2025
Medtronic USD 2.58B 26M Sep/2025
Philips EUR 1.93B 214M Dec/2025
Ramsay Health Care AUD 1.73B 76.3M Jun/2025
ResMed USD 250.41M 16.37M Dec/2025
Sigma Healthcare AUD 1.32B 970.03M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Steris USD 285.1M 23.8M Dec/2025
Teleflex USD 165.91M 8.35M Sep/2025
Thermo Fisher Scientific USD 3.12B 140M Sep/2025